|
Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute …
MarketWatch (press release) SOUTH SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire via COMTEX/ — Rigel Pharmaceuticals, Inc., (NASDAQ:RIGL) is expanding its respiratory franchise by focusing on two innovative, comprehensive treatment alternatives for patients with asthma. |
View full post on asthma – Google News